Evotec ex­pands pres­ence in Italy with ac­qui­si­tion of for­mer Glax­o­SmithK­line R&D site

Ger­many-based Evotec es­tab­lished its pres­ence in Italy four years ago. Now, it’s bought up more re­al es­tate in the neigh­bor­hood.

Evotec has ac­quired an R&D site in Verona from GSK, the com­pa­ny an­nounced Thurs­day. The com­pa­ny did not dis­close fi­nan­cial de­tails of the deal.

GSK used the site for the spe­cial­ized man­u­fac­tur­ing of fin­ished dose form of cephalosporin. It fea­tures ster­ile pow­der fill to vials, mono­rails and Add-Van­tage vials and flex­i­ble pack­ag­ing lines. It’s ap­proved by the FDA and EMA, as well as and has main­tained glob­al reg­u­la­to­ry ap­provals.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER